Tag: Bharat Biotech

Research

COVAXIN Phase-III Results; Demonstrates Clinical Efficacy of 78%, 100% efficacy against Severe COVID-19 disease

13 May 2021
Anuj K Tiwari

Bharat Biotech, an Indian origin global leader in vaccine innovation, developing vaccines for infectious diseases, announced…

Research

Covaxin, Most-Effective Against B.1.617 Variant of Coronavirus; White House’s Dr Fauci Says

28 April 2021
Subro Prakash

While so-called experts in India, and few notorious journalists had started a negative campaign against the…

Science

India’s first Indigenous COVID-19 Vaccines in The Race to End Global Pandemic

5 July 2020
Staff Reporter

In the past years, India has emerged as one of the significant vaccine manufacturing hubs. Indian…